GeneBioTech Co. Ltd (086060) — Capital Reinvestment Ratio
GeneBioTech Co. Ltd (086060) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩2.15 Billion) in capital expenditures (₩96.62 Million). Check GeneBioTech Co. Ltd (086060) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GeneBioTech Co. Ltd Capital Reinvestment Ratio (2009–2025)
This chart tracks GeneBioTech Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see cash flow conversion of GeneBioTech Co. Ltd.
Annual Capital Reinvestment Ratio for GeneBioTech Co. Ltd (2009–2025)
Year-by-year Capital Reinvestment Ratio for GeneBioTech Co. Ltd from 2009 to 2025. See 086060 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | ₩7.61 Billion | ₩3.76 Billion | ▲ +374.4% |
| 2023 | 0.10x | ₩7.37 Billion | ₩766.93 Million | ▼ -94.1% |
| 2020 | 1.76x | ₩2.49 Billion | ₩4.39 Billion | ▲ +1777.2% |
| 2018 | 0.09x | ₩5.96 Billion | ₩558.47 Million | ▼ -90.4% |
| 2017 | 0.98x | ₩1.13 Billion | ₩1.11 Billion | ▲ +300.8% |
| 2016 | 0.24x | ₩5.31 Billion | ₩1.30 Billion | ▼ -31.5% |
| 2015 | 0.36x | ₩2.61 Billion | ₩927.06 Million | ▲ +50.2% |
| 2014 | 0.24x | ₩2.15 Billion | ₩510.55 Million | ▼ -3.2% |
| 2013 | 0.24x | ₩2.38 Billion | ₩582.01 Million | ▼ -75.4% |
| 2011 | 0.99x | ₩2.53 Billion | ₩2.51 Billion | ▲ +66.9% |
| 2010 | 0.60x | ₩1.17 Billion | ₩693.45 Million | ▲ +593.8% |
| 2009 | 0.09x | ₩2.68 Billion | ₩229.99 Million | — |